Axogen (AXGN) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.89% |
| Dec 31, 2025 | -13.30% |
| Sep 30, 2025 | 20.11% |
| Jun 30, 2025 | 15.44% |
| Mar 31, 2025 | 17.55% |
| Dec 31, 2024 | 15.50% |
| Sep 30, 2024 | 22.16% |
| Jun 30, 2024 | 25.98% |
| Mar 31, 2024 | 8.97% |
| Dec 31, 2023 | 7.09% |
| Sep 30, 2023 | 1.89% |
| Jun 30, 2023 | 4.36% |
| Mar 31, 2023 | -1.22% |
| Dec 31, 2022 | -13.18% |
| Sep 30, 2022 | -10.76% |
| Jun 30, 2022 | -24.57% |
| Mar 31, 2022 | -19.67% |
| Dec 31, 2021 | 6.73% |
| Sep 30, 2021 | -16.27% |
| Jun 30, 2021 | -16.12% |
| Mar 31, 2021 | -5.92% |
| Dec 31, 2020 | -4.56% |
| Sep 30, 2020 | 18.32% |
| Jun 30, 2020 | -9.00% |
| Mar 31, 2020 | -5.59% |
| Dec 31, 2019 | 12.45% |
| Sep 30, 2019 | 5.92% |
| Jun 30, 2019 | 3.04% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 9.99% |
| Sep 30, 2018 | 15.14% |
| Jun 30, 2018 | 8.39% |
| Mar 31, 2018 | 12.39% |
| Dec 31, 2017 | 27.93% |
| Sep 30, 2017 | 21.40% |
| Jun 30, 2017 | 7.79% |
| Mar 31, 2017 | 10.35% |
| Dec 31, 2016 | -15.39% |
| Sep 30, 2016 | 50.15% |
| Jun 30, 2016 | 44.11% |
| Mar 31, 2016 | 44.16% |
| Dec 31, 2015 | 47.18% |
| Sep 30, 2015 | 36.31% |
| Jun 30, 2015 | -21.06% |